Ethinylestradiol/levonorgestrel - MEDA PharmaAlternative Names: Evaluna
Latest Information Update: 17 Mar 2016
At a glance
- Originator Meda Pharma GmbH & Co KG
- Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
Most Recent Events
- 17 Mar 2016 MEDA Pharma initiates a phase III trial for the prevention of pregnancy in Germany (EudraCT2012-004762-18)